Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Peptron, Inc.
No Price
Closing Price XKOS 29.04.2026:
268.500,00 KRW
29.04.2026 03:10
Current Prices from Peptron, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
KOSDAQ
087010.KQ
KRW
29.04.2026 03:10
268.500,00 KRW
-2.000,00 KRW
-0,74 %
Share Float & Liquidity
Free Float91,53 %
Shares Float21,27 M
Shares Outstanding23,24 M
Company Profile for Peptron, Inc. Share
Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
